Catabasis Pharma (CATB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | CATB | PMN | FBIO | ||
Company | Catabasis Pharma | Promis Neurosciences Inc | Fortress Biotech Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 9.21 | 1.9000 | 1.7100 | ||
High | 9.21 | 1.9200 | 1.7699 | ||
Low | 8.46 | 1.7200 | 1.6500 | ||
Last | 8.54 | 1.8900 | 1.6700 | ||
Change | -0.64 | +0.1000 | -0.0400 | ||
% Change | -6.97% | +5.59% | -2.34% | ||
Volume | 98,800 | 4,400 | 152,000 | ||
20-Day Average Volume | 395,311 | 9,290 | 169,045 | ||
Previous Close | 9.18 | 1.7900 | 1.7100 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | No | Yes | ||
Technicals | |||||
20-Day Moving Average | 8.72 | 1.9686 | 1.7535 | ||
20-Day Raw Stochastic | 56.46% | 49.00% | 8.70% | ||
20-Day Relative Strength | 43.24% | 46.64% | 41.66% | ||
Weighted Alpha | -50.43 | -74.50 | -78.39 | ||
Today's Opinion | 88% Sell | 24% Buy | 100% Sell | ||
Previous Opinion | 72% Sell | 8% Sell | 100% Sell | ||
Last Month's Opinion | 100% Sell | 56% Buy | 96% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -14.34% since 08/31/21 | -3.57% since 05/03/24 | -4.57% since 05/03/24 | ||
Low | 8.46 on 09/08/21 | 1.7200 on 05/10/24 | 1.6500 on 05/10/24 | ||
High | 10.26 on 09/02/21 | 2.1500 on 05/06/24 | 1.8500 on 05/08/24 | ||
1-Month | |||||
%Chg | -8.17% since 08/06/21 | -21.25% since 04/10/24 | -12.57% since 04/10/24 | ||
Low | 6.31 on 08/20/21 | 1.4000 on 05/01/24 | 1.6500 on 05/10/24 | ||
High | 10.26 on 09/02/21 | 2.5450 on 04/11/24 | 1.9200 on 04/11/24 | ||
3-Month | |||||
%Chg | -34.10% since 06/08/21 | -5.97% since 02/09/24 | -10.70% since 02/09/24 | ||
Low | 6.31 on 08/20/21 | 1.4000 on 05/01/24 | 1.6300 on 03/14/24 | ||
High | 15.72 on 06/16/21 | 2.6100 on 04/10/24 | 2.6150 on 03/04/24 | ||
6-Month | |||||
%Chg | -50.23% since 03/08/21 | +32.56% since 11/10/23 | +27.48% since 11/10/23 | ||
Low | 6.31 on 08/20/21 | 0.9500 on 12/26/23 | 1.2800 on 11/13/23 | ||
High | 22.01 on 03/18/21 | 3.1000 on 01/16/24 | 4.4300 on 12/28/23 | ||
Key Statistics | |||||
Market Capitalization, $K | 33,337 | 33,940 | 32,892 | ||
Shares Outstanding, K | 3,904 | 18,961 | 19,235 | ||
Annual Sales | 0 | 0 | 84,510,000 | ||
Annual Net Income | -37,300,000 | -13,210,000 | -60,640,000 | ||
Last Quarter Sales | 0 | 0 | 19,950,000 | ||
Last Quarter Net Income | -7,470,000 | -3,580,000 | -9,280,000 | ||
60-Month Beta | 1.66 | 0.67 | 1.56 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.09 on 04/01/24 | -0.53 on 03/28/24 | ||
Latest Earnings Date | 08/09/21 | 05/20/24 | 05/20/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |